Primary Care Medicine: On Demand 5.2
|
$500.00
Use promo code (Limited Offer)
20 CREDITS
  Hurry! Offer expires June 30, 2023 at 11:59 pm ET!
|
|
A collection of recorded video lectures from recent conferencesCourse Content
| Session | Title | Faculty |
| Session 1 (55 minutes) | Sex Difference in Cardiovascular Disease | M. Gulati, MD |
| Session 2 (57 minutes) | When to Worry: Adverse Cutaneous Drug Eruptions for Primary Care | M. Maiberger, MD |
| Session 3 (60 minutes) | It's Not Always a Seborrheic Keratosis: Recognizing and Treating Non-melanoma Skin Cancers | M. Maiberger, MD |
| Session 4 (50 minutes) | How to Integrate SGLT2 Inhibitors and GLP-1 Receptor Agonists into Primary Care | K. Kulasa, MD |
| Session 5 (68 minutes) | CV Risk Assessment: Equations, Biomarkers and Imaging | D. Soffer, MD |
| Session 6 (59 minutes) | Cholesterol Management: A Case Based Discussion | S. Virani, MD, PhD |
| Session 7 (72 minutes) | Endocrinology Potpourri | K. Pantalone, DO |
| Session 8 (58 minutes) | The Ins and Outs of Chronic Constipation | W. Chey, MD |
| Session 9 (62 minutes) | Non-Pharmacologist IBS Therapies: Soup to Nuts | W. Chey, MD |
| Session 10 (47 minutes) | All Things Gluten: Evaluation and Management of Celiac Disease and Non-Celiac Sensitivity | A. Stein, MD |
| Session 11 (72 minutes) | Hepatitis C: Issues and Implications for Your Practice | B. Pearlman, MD |
| Session 12 (54 minutes) | Update on Resistant Hypertension | J. Basile, MD |
| Session 13 (47 minutes) | Hypertension Over a Women's Lifespan | M. Gulati, MD |
| Session 14 (57 minutes) | Improving Patient Outcomes in Chronic Kidney Disease | M. Weir, MD |
| Session 15 (45 minutes) | Medical Management of Common Co-Morbid Problems of Obesity | K. Fujioka, MD |
| Session 16 (43 minutes) | Overuse Injuries: Tennis Elbow, Jumpers Knee, Runners Knee, Planter Fasciitis and More | D. Campagne, MD |
| Session 17 (60 minutes) | High Yield Orthopedic Physical Exam | D. Campagne, MD |
| Session 18 (58 minutes) | Ten Principles for Practical Antidepressant Prescription | J. Bostwick, MD |
| Session 19 (57 minutes) | Allergic Rhinitis: The Old, The New, and The Confusing | D. Khan, MD |
| Session 20 (54 minutes) | Options for Contraceptive Management | K. Roussos-Ross, MD |
| Session 21 (61 minutes) | Perimenopausal Mood Disorders: How to Identify and Treat | K. Roussos-Ross, MD |
Program Overview
Presented by Continuing Education Company (CEC) for the past 29 years, our Primary Care CME Conference Series is designed to update primary care clinicians in rapidly changing therapeutic areas. This CME activity is comprised of recorded video lectures from recent conferences. The emphasis of this course is on practical and useful information for clinical practice.
This CME program will educate and promote improved patient outcomes in a broad range of therapeutic areas commonly encountered in the primary care practice. This activity will highlight the latest science related to a variety of specialty areas, presented in a practical and patient-focused manner relevant to the primary care setting.
Learning Objectives:
As a result of this educational activity, participants should be better able to:
- Assess and provide patients with an accurate diagnosis and optimal care for a broad range of disorders seen in primary care.
- Utilize current guidelines in the diagnosis and management of commonly encountered therapeutic issues.
- Formulate comprehensive evidence-based interventions and treatment strategies that will lead to the reduction of modifiable risk factors and improved long term outcomes.
Post-Test and Evaluation:
After completing the CME activity, you must successfully complete a post-test and fill out a program evaluation form. You will then be able to view and print your CME certificate. Login into CME365 to view your transcript and reprint your certificate at any time.
Faculty
Jan N. Basile, MD, FACP, FASH, FAHA
Professor of Medicine
Seinsheimer Cardiovascular Health Program
Medical University of South Carolina
Ralph H Johnson VA Medical Center
Previous Vice-Chair of Clinical Programs AHA Council of Hypertension
US National Leader SURPASS-CVOT
Charleston, SC
J. Michael Bostwick, MD
Professor of Psychiatry
Department of Psychiatry and Psychology
Mayo Clinic
Rochester, MN
Danielle D. Campagne, MD, FACEP
Vice Chair of Emergency Medicine, UCSF-Fresno
Associate Professor of Clinical Emergency, UCSF
Fresno, CA
William D. Chey, MD
Nostrant Collegiate Professor of Gastroenterology & Nutrition
Michigan Medicine
Ann Arbor, MI
Ken Fujioka, MD
Director, Nutrition and Metabolic Research Center
Center of Weight Management
Diabetes and Endocrinology
Scripps Clinic Medical Group
San Diego, CA
Martha Gulati, MD, MS, FACC, FAHA
Division Chief, Cardiology
UA College of Medicine
Physician Director
Banner - University Medicine Heart Institute
Phoenix, AZ
David A. Khan, MD
Program Director, Allergy & Immunology Fellowship Program
Professor of Medicine and Pediatrics
UT Southwestern Medical Center
Dallas, TX
Kristen Kulasa, MD
Clinical Professor of Medicine
Chief, Division of Endocrinology, Diabetes and Metabolism
Director, Inpatient Glycemic Control
University of California, San Diego
San Diego, CA
Mary Maiberger, MD, FAAD
Assistant Clinical Professor of Dermatology
George Washington University School of Medicine
Chief of Dermatology
Washington DC VA Medical Center
Washington, DC
Kevin M. Pantalone, DO, ECNU, FACE
Staff Endocrinologist
Director of Clinical Research, Department of Endocrinology
Cleveland Clinic
Cleveland, OH
Brian Pearlman, MD, FACP, FAASLD, AAHIVS
Medical Director, Center for Hepatitis C, Wellstar Atlanta Medical Center
Professor of Medicine, Medical College of Georgia
Professor of Medicine, Emory School of Medicine
Atlanta, GA
Dikea (Kay) Roussos-Ross, MD
Associate Professor
Division Director Gynecology, Gynecologic Surgery, and Obstetrics
Department of Obstetrics and Gynecology
University of Florida College of Medicine
Gainesville, FL
Daniel E Soffer, MD, FNLA, FACP
University of Pennsylvania Health System
Perelman School of Medicine at the University of Pennsylvania
PennCare Media
Penn Medicine at Radnor
Perelman Center for Advanced Medicine, Philadelphia
Adam C. Stein, MD
Assistant Professor of Medicine
Division of Gastroenterology and Hepatology
Northwestern University Feinberg School of Medicine
Chicago, IL
Salim S. Virani, MD, PhD, FACC, FAHA
Professor, Section of Cardiovascular Research
Director, Cardiology Fellowship Training Program
Baylor College of Medicine
Staff Cardiologist, Michael E. DeBakey VA Medical Center
Houston, TX
Matthew R. Weir, MD
Professor of Medicine
Chief of Nephrology Division
University of Maryland School of Medicine
Baltimore, MD
Accreditation
AMA PRA Category 1 Credits™: Continuing Education Company, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education Company designates this enduring material for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 20 hours of Category 1 credit for completing this activity.
AANPCB: The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Nurse Practitioners may receive a maximum of 20 hours of participation, 8 of which can be used towards Pharmacology, for completing this activity.
Release Date: 9/27/2021
Expiration Date: 9/27/2024 (Date after which this enduring material is no longer certified for credit.)
Medium: Internet/Enduring Material, Video/Audio
Faculty/Planning Committee Disclosures
Review and Planning Committee Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) has no relevant financial relationships with a commercial interest that may impact upon this CME activity:
- Raymond E. Major - Reviewer
- Walter Ejnes, CHCP - Reviewer & Planning Committee (Continuing Education Company)
- Beth Townsend - Reviewer (Continuing Education Company)
- Su Barnwell - Planning Committee (Continuing Education Company)
Faculty Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) have no relevant financial relationships with a commercial interest that may impact upon this CME activity:
| Faculty | Disclosure |
| Jan N. Basile, MD, FACP, FASH, FAHA | Consultant: Medtronic Adjudication Committee (Symplicity AF Hypertension Study) and Up to Date Research Grant: Ablative Solutions (Target BP I), Eli Lilly, Medtronic, and ReCor (RADIANCE I and II) |
| J. Michael Bostwick, MD | Nothing to Disclose |
| Danielle D. Campagne, MD, FACEP | Nothing to Disclose |
| William D. Chey, MD | Board Membership: ACG, ANMS, IFFGD, and Rome Foundation Consultant: Abbvie/Allergan, Alnylam, Arena Pharmaceuticals, Ferring, IM Health, Ironwood, Phathom, and Takeda Consultant, Board Membership, Ownership Interest: GI OnDEMAND Consultant, Ownership Interest: Ritter Consultant, Research Grant: Biomerica, QOL Medical, Salix, Urovant, and Vibrant Ownership Interest: Modify Health Patent: Digital Manometry and Rectal Expulsion Devise Research Grant: Commonwealth Diagnostics International and Zespri |
| Ken Fujioka, MD | Consultant: Amgen, Boehringer-Ingelheim, Gelesis, Janssen Global Services, KVK Tech, Phenomix, Riovant, and Sunovion Pharmaceuticals Advisory Board, Consultant, Honorarium, Speaker Bureau: Novo Nordisk |
| Martha Gulati, MD, MS, FACC, FAHA | Nothing to Disclose |
| David A. Khan, MD | Nothing to Disclose |
| Kristen Kulasa, MD | Nothing to Disclose |
| Mary Maiberger, MD, FAAD | Nothing to Disclose |
| Kevin M. Pantalone, DO | Advisory Board, Consultant, Research Grant, Speakers Bureau: Merck and Novo Nordisk Consultant: Bayer, Corcept Therapeutics, Eli Lilly, and Sanofi Consultant, Speakers Bureau: AstraZeneca |
| Brian Pearlman, MD, FACP, FAASLD, AAHIVS | Advisory Board, Honoraria, Research Grant, Speakers Bureau: Gilead Sciences Consultant, Honoraria, Research Grant, Speakers Bureau: Abbvie and Merck Research Grant: Genfit and Novartis |
| Dikea (Kay) Roussos-Ross, MD | Nothing to Disclose |
| Daniel E Soffer, MD, FNLA, FACP | Advisory Board: Medicure Advisory Board, Clinical Trial Investigator: Novartis Clinical Trial Investigator: Akcea Therapeutics, Astra-Zeneca, Regeneron, and RegenXBio Consultant, Clinical Trial Investigator: Amgen Speaker’s Bureau: Kaneka |
| Adam C. Stein, MD | Speakers Bureau: Alcresta Speakers Bureau, Advisory Board: Abbvie and Pfizer |
| Salim S. Virani, MD, PhD | Member, Steering Committee: Patient and Provider Assessment of Lipid Management (PALM) and Registry at the Duke Clinical Research Institute Research Grant: American Diabetes Association, American Heart Association, Baylor College of Medicine Center for Globalization, and Department of Veteran Affairs |
| Matthew R. Weir, MD | Advisory Board: Astra, Bayer, Boehringer-Ingelheim, CareDX, Janssen, MSD, and Vifor Pharma Research Grant: National Institute of Diabetes and Digestive Kidney: R01DK 066013, NHLBI: R01HL127422, R01HL132732, U01DK106102, and U01DK116095 |
Unlabeled Use Declaration:
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
Statement of Disclosure and Independence:
It is the policy of Continuing Education Company (CEC) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, CEC has Relevant Financial Relationship Disclosure Policies that are designed to ensure that accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.
All individuals who are in position to influence and/or control content of a CEC accredited Continuing Medical Education (CME) activity must disclose any relevant financial interest or other relationships they have with an ineligible company, which is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. (Relevant financial interest or other relationship includes such things as grants or research support, employee, consultant, major stockholder, member of speakers’ bureau, etc.) The intent of this disclosure is to provide activity participants with information to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusions. All relevant financial relationships have been identified, mitigated, and are listed above.
The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentations at this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Continuing Education Company, advisory boards or consultants.
Computer Requirements
Flash Player 10 or later, and one of the following browsers:
- Windows: Internet Explorer 6 and later, Microsoft Edge (latest version), Firefox 1.x and later, Google Chrome (latest version), Opera 9.5 and later
- Mac: Safari 3 and later, Firefox 1.x and later, Google Chrome (latest version)
- Linux: Firefox 1.x and later
HTML5 via one of the following browsers:
- Windows: Google Chrome (latest version)
- Mac: Safari 6.0.5 or later, Google Chrome (latest version)
- Mobile: Safari in Apple iOS 6 or later
30 Day Money Back Guarantee
CEC stands behind our product. If you are not satisfied with your online course for any reason, send a written cancellation request and reason to registration@cmemeeting.org within 30 days of the purchase date for a full refund. (Cancellations on CME365™ Collection Series will incur a 5% processing fee.) Please note you may watch any of the content but once you claim credit for any online course, no refund can be granted.